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U.S. Sperm Trend
Conclusions
The letter written by Heinze (1) has seri-
ous shortcomings. Heinze wrote that
There is not a single study ofhealthy men from
any fertility center or sperm bank that has
reported a decline in sperm counts in the United
States.
This is not true. A number ofsuch studies
exist. Leto and Frensilli (2) documented a
decline in sperm counts in potential sperm
donors from all over the United States in a
longitudinal study.
Heinze stated that
A study by MacLeod and Wang (3) indicates
that sperm counts have remained constant in
NewYork since 1938.
That study was dated 1979 and was on
men ascertained at a fertility center.
Although their sperm counts were stable
over the years preceding 1979, it does not
necessarily follow that sperm counts offer-
tile men were stable too.
William H.James
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University College London
London, United Kingdom
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U.S. Sperm Trend: Response
Iwould like to respond toJames's comments
on myletter "Regional Differences Invalidate
U.S. SpermTrendConclusions" (1).
Perhaps I should have said that
There is not a single [confirmed] study of
healthy men from any fertility center or sperm
bank that has reported a decline in sperm counts
in the United States.
The study ofLeto and Frensilli (2) is con-
tradicted by the four longitudinal studies
cited in my letter, which report no decline
in sperm counts in five regions of the
United States over periods ranging from
10 to 30 years (1). Earlier data on trends in
sperm counts were reviewed by MacLeod
and Wang (3), who concluded that
enough data have been presented to indicate that
there has not been a substantial change in the
numerical aspect ofsemen quality.
Saidi et al. (4), in a recently published
review of 29 U.S. studies from the late
1930s to the late 1990s, found "no signifi-
cant changes in sperm counts during the
last 60 years."
MacLeod and Wang (3) reviewed all of
the U.S. data available up to that time
(1979), including data from fertile men as
well as from men evaluated at a fertility
center. The earliest data on sperm counts in
New York City, published in 1938 (5),
were on prenatal couples (i.e., men of
known fertility); mean counts (137 x
106/mL) from this study are virtually iden-
tical to the mean counts (131.5 x 106/mL)
reported in the most recent study from
New York City published in 1996 (6),
which focused on donors to sperm banks
(i.e., men ofunknown fertility).
John Heinze
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Comments on "Drinking
Water Arsenic in Utah: A
Cohort Mortality Study"
Lewis et al. (1) compared the mortality ofa
cohort of members of the Church ofJesus
Christ of Latter-day Saints (also known as
Mormons) who were exposed to relatively
high levels ofarsenic through drinkingwater
to the mortality ofthe general population of
Utah. The authors concluded that arsenic
exposure may be associated with hyperten-
sive heart disease, nephritis and nephroma,
prostate cancer in men, and other heart dis-
ease in women. No excess risks were report-
ed for cancers such as those ofthe skin and
bladder, which have been associated with
arsenic in other studies (4. We believe that
the comparison group used in this study,
and theweight given on external rather than
internal comparisons, complicates the inter-
pretation ofthe study results.
Mormons are a selected group that dif-
fers from other groups ofthe general popu-
lation in many ways, including lifestyle
factors such as smoking, which are strong
determinants of health. Lewis et al. (1)
acknowledged that the study group is
known to have about one-halfthe mortali-
ty rates of the general population for dis-
eases such as respiratory and bladder can-
cers. Given this strong selection bias, it
would be unlikely to find any excess risks
for these diseases unless this risk associated
with arsenic was very high. Similarly, high
standard mortality ratios (SMRs) are likely
to be caused by other general lifestyle fac-
tors, rather than arsenic in drinkingwater.
When the external comparison group is
very different from the index group and
information on potential confounders is
not available, the best solution is to per-
form internal comparisons. If conclusions
had been based on internal comparisons,
neither hypertensive heart disease (SMRs
of2.4, 1.9, and 2.3 for low, medium, and
high exposure to arsenic, respectively),
nephritis/nephroma (SMRs of 2.0, 2.1,
and 0.9, respectively), nor all other heart
diseases (SMRs of 2.3, 1.4, and 0.7,
respectively) would probably have been
associated with arsenic in this study.
Among the four causes that Lewis et al. (1)
reported to be associated with arsenic, an
increasing riskwith exposure was only seen
for prostate cancer. The authors did men-
tion that internal comparisons are planned.
Although such comparisons may be limit-
ed by small numbers, any conclusions
from this study should await the conduct
ofsuch analyses.
CristinaVilllanueva
Manolis Kogevinas
Respiratory and Environmental
Health Research Unit
Institut Municipal d'Investigacio Medica
Barcelona, Spain
E-mail: cvillanueva@imim.es
REFERENCES AND NOTES
1. Lewis DR, Southwick JW, Ouellet-Hellstrom R,
Rench J, Calderon RL. Drinking water arsenic in
Utah: a cohort mortality study. Environ Health
Perspect 107:359-365(1999).
2. Cantor KP. Drinking water and cancer. Cancer
Causes Control 8:292-308(1997).
"Drinking Water Arsenic in
Utah ...": Response
We thank Villanueva and Kogevinas for
their letter based on our recent article (1).
We agree that to interpret the results of
thils paper it iS important to keep in mind
the characteristics of the population used
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to generate the expected numbers. Of the
populations readily available to generate
the expected numbers, we considered the
white population of males and females
from the state of Utah to be the best. We
used white male and white female death
rates from the state ofUtah as the external
comparison group. For noncancer causes
of death, we used Utah white male and
female rates for 1960-1992 to estimate the
expected number of noncancer deaths,
and we used Utah white male and female
rates from 1950 to 1992 to estimate the
expected number of cancer deaths. Based
on a 1982 report, nearly 73% of the state
ofUtah is Mormon (2), whereas our mor-
tality cohort was 100% Mormon. Given
that a majority of those in Utah are
Mormon, our study population and the
external Utah population would not be
expected to differ greatly on average for
many lifestyle factors including smoking.
Therefore, we believe there are minimal
differences between the external compari-
son group (in our case, white men and
women in the state ofUtah, which is pre-
dominantly Mormon) and our index
group (which is by definition 100% white
Mormons). To avoid any misunderstand-
ing, we did not use death rates from the
U.S. general population as the basis ofthe
expected numbers, which would have been
more different from the index group on
potentially confounding factors. We made
no attempt to generalize our results back to
the U.S. population.
Although we agree that Mormons are a
select group with many healthy lifestyle
habits, we do not think that selection bias
had a significant effect in this study, as sug-
gested by Villanueva and Kogevinas. We
did not claim that the study group had
one-halfthe rates ofmortality for respirato-
rydiseases and bladder cancer than the gen-
eral population, but rather that Mormon
men in general had one-half of the inci-
dence of these smoking-related health
effects as compared with U.S. men. The
difference in these rates would not con-
tribute to selection bias in the context of
our study. Selection bias is caused by sys-
tematic differences in characteristics
between those who are selected for a study
and those who are not (3) and results in
error in the measure ofassociation. Because
we took a nearly complete sample ofhistor-
ically registered Mormons for this part of
Millard County, Utah, selection bias (if
any) played a very minor role, as over 90%
of the people living in these areas at that
time were registered in the historic
Mormon church membership records. The
loss to follow-up for the mortality cohort
was also low.
Historically, Utah has had among the
lowest mortality rates for bladder cancer
and lung and bronchus cancer in the
United States (4). The lack ofa finding for
bladder cancer and respiratory diseases is
due to the rareness ofthese events in Utah.
For bladder cancer, only five deaths were
reported. As we discussed in our paper (1),
the rates of smoking for other areas in
Utah are higher than for Millard County.
We would expect the SMR for respiratory
conditions (expected number generated
from the state ofUtah rates) to be less than
1.0. This finding makes sense based on
what we know about the two populations
(our cohort and the population of Utah)
with regard to smoking. In the review
paper cited by Villanueva and Kogevinas
in their letter (5), none of the articles
reviewed indicate an excess ofskin or blad-
der cancer from the studies that were con-
ducted in U.S. populations. In addition, a
previously conducted case-control study of
bladder cancer and arsenic in drinking
water in Utah did not find an overall asso-
ciation of inorganic arsenic with risk of
bladder cancer (6). In assessing the two
populations in our mortality analysis, one
factor for which this part of Millard
County, Utah (from which the index
group is drawn), and the rest of Utah
(external comparison group) differs is the
concentration of arsenic in the water. On
average, Millard County has had the high-
est concentrations of arsenic in the state
from both public and private wells over the
last 20 years (7). Without further informa-
tion on individual exposure to arsenic in
drinking water, one could assume that the
concentration of arsenic may play some
role in the health ofthis community; how-
ever, a causal association based on this
analysis alone would be inappropriate.
Villanueva and Kogevinas suggest that
any conclusions from this study should
await the conduct of analyses using inter-
nal comparisons. However, while we are
completing our internal comparisons
analysis, we do not think it is incorrect to
evaluate the relationships between arsenic
concentration and causes ofmortality from
these results as long as one keeps in mind
the source and the characteristics of the
external (comparison) population and the
fact that this is a single study. Villanueva
and Kogevinas indicate that they believe
certain increasing effects that appeared in
this analysis for hypertensive heart disease,
nephritis and nephrosis, and all other heart
diseases would not be apparent ifan inter-
nal comparison group had been used in the
analysis. However, it is quite possible to
have results for a condition that are in the
same direction (both increased or both
decreased) from either type ofanalysis that
uses internal or external comparison
groups. We plan to note the similarities
and differences between our SMR results
and the forthcoming relative risk results
based on internal comparisons. The rela-
tionships between low, medium, and high
exposure groups in this analysis are less
apparent because ofpotential differences in
the age structure from the subcohort analy-
sis. SMRs are generally not directly compa-
rable, even ifthe same standard population
is used to generate the expected numbers.
Finally, we want to emphasize the
importance ofconducting population stud-
ies and our original goal in conducting the
study. Population studies, and more impor-
tantly SMR analyses, play an important
role in identifying important risk factors or
hazards. We were interested in determining
whether studies of health effects related to
arsenic in drinking water could be conduct-
ed in U.S. populations exposed to relatively
low concentrations ofarsenic, as compared
to many international populations that
have reported effects, often at higher con-
centrations. We also were interested in
determining which health effects may be
more meaningful to study in U.S. popula-
tions. This cohort provided the opportunity
not only to evaluate cancer effects but also
noncancer effects. We believe mortality
studies are one way to identify potential
hypotheses for further testing. The relation-
ships between the health effects and arsenic
in drinkingwater in this study are consistent
with those reported in otherpopulations and
should be considered when planning further
studies ofarsenicand U.S. populations.
Denise Riedel Lewis
Rebecca L. Calderon
National Health and Environmental
Effects Research Laboratory
U.S. Environmental Protection Agency
Research Triangle Park, North Carolina
E-mail: lewis.denise@epa.gov
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SRA Life Sciences
Falls Church, Virginia
Jerry Rench
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Comments on "Why Not Use
It All?"
The recent editorial by George Lucier (1)
mischaracterizes the two key aspects ofthe
Society of Toxicology (SOT)-European
Society of Toxicology (EUROTOX)
debate, which was a part ofthe program of
the March 1999 SOT Annual Meeting
held in New Orleans, Louisiana. First, the
debaters represented neither an SOT
motion nor a EUROTOX motion, i.e., this
is not a situation where the two societies
have taken an official position on an issue.
Second, the debate was not intended to
persuade the audience to simply accept one
side and jettison the data presented by the
other side. The SOT-EUROTOX debate
provides a public forum for airing different
viewpoints and differences in interpretation
of data surrounding a scientific issue. It is
framed deliberately in a provocative fashion
to stimulate an open, thorough discussion.
This type ofdiscussion facilitates introspec-
tion and leads to an enhanced understand-
ing ofthe issue at hand.
The particular debate in question
focused upon the following hypothetical
motion: "The Results of Mechanistic
Toxicity Studies Should Supersede
Ambiguous Epidemiological Data." This
debate was a part ofan annual cooperative
activity between two of the largest profes-
sional organizations of toxicologists in the
world: the SOT and EUROTOX. A topic
chosen jointly by the program committee
of each society is debated at each society's
annual meeting, the SOT meeting in
March and the EUROTOX meeting in
June. The two program committees select
a member oftheir respective society to par-
ticipate in the debate, and the same indi-
viduals debate the issue in the United
States and in Europe. In addition to select-
ing a new topic and new debaters each
year, the "side" that each society takes
changes yearly, i.e., in even-numbered
years EUROTOX speaks for the motion
and SOT speaks against it, whereas the
SOT speaks for the motion and EURO-
TOX against it in odd-number years.
Importantly, the topic does not represent
an official position of either society.
Rather, a considered extreme "pro" and
"con" side of the issue is set initially to
force each side to marshal their best ratio-
nale. Furthermore, substantial time for
audience participation is an integral com-
ponent ofthe program. Over the years we
have learned that this format facilitates an
open discussion that entails the presenta-
tion of a full range of views leading to a
more thorough understanding of the issue
at hand. Often an individual debater may
speak to an issue in which he or she has an
extensive record of publication; however,
this is not always the case. The prime
objective is to select debaters who will
develop strong arguments for the side they
are taking in a fashion analogous to an
attorney making the best argument for his
or her client.
Contrary to Lucier's editorial (1), this
format not only permits, but indeed
demands, full consideration of all relevant
data sets. The scientific expertise of the
chosen debaters plus the public nature of
the debate, combined with ample time for
both questions and comments from the
audience, ensures that this occurs. It is not
a simple case of choosing between two
opposite poles. Experience has demonstrat-
ed the scientific value of the debate. It
serves to enhance critical, constructive
thinking concerning the issue at hand.
Typically, this session draws a packed
room and, judging by the attentiveness of
the audience and their enthusiastic partici-
pation in the discussion, it is a highly val-
ued component ofour annual meeting.
We welcome more open dialog on the
value ofthis and other specific components
of the SOT annual meeting program,
which is intended to provide an interna-
tional forum for discussion of important
and sometimes controversial issues related
to the science oftoxicology.
Jay I. Goodman
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SocietyofToxicology
Reston, Virginia
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"Why Not Use It All?":
Another View
I join enthusiastically in Lucier'swell crafted
editorial argument (1) that full assessment
of the carcinogenic potential of chemical
compounds requires examination of epi-
demiologic, toxicologic, and mechanistic
data. To ignore information from any of
these three sources would be wasteful,
short-sighted, and not in the best interests
ofprotecting public health.
There is, however, afourth dimension of
carcinogenic risk assessment that has not to
date received adequate consideration. This is
the developmental dimension. The young of
all mammalian species have exposures and
vulnerabilities to chemical carcinogens that
are qualitatively and quantitatively different
from those ofadults. The special susceptibil-
ities of human babies were examined in
detail in the 1993 National Academy of
Sciences report Pesticides in the Diets of
InfantsandChildren (2).
The EPA Guidelines on Carcinogenic
Risk Assessment, on which Lucier com-
ments in his editorial (1), pay only scant
attention to developmental biology. The
current draft of these guidelines continues
to embody the outmoded fiction that the
entire American population can be repre-
sented by an adult white male who weighs
70 kg. Until our national policy on car-
cinogen risk assessment moves beyond this
limiting assumption and begins to require
explicit consideration of pediatric expo-
sures and risks, there will be little incentive
for researchers to explore pathways of
exposure, patterns of disease, or mecha-
nisms of carcinogenesis in the young. We
are not yet usingall ofthe data.
PhilipJ. drigan
Community & Preventive Medicine
Mount Sinai School ofMedicine
NewYork, NewYork
E-mail: phil.landrigan@mountsinai.org
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Air Toxics Concentrations of
Methyl Chloride
On behalfofthe Methyl Chloride Industry
Association (MCIA; which comprises the
following domestic producers of methyl
chloride: Dow Chemical Company, Dow
Corning Corporation, General Electric
Company, and Vulcan Materials
Company), I would like to alert you to cer-
tain incorrect statements concerning methyl
chloride contained in "Public Health
Implications of 1990 Air Toxics
Concentrations across the United States"
(1). In this letter, I will briefly summarize
these incorrect statements and provide a
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